Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News

Cardiomyopathy-Causing Gene Variants Linked to Risk for AF

An analysis of two large cohort studies finds that carriers of disease-causing variants within genes for three cardiomyopathies were at higher risk for atrial fibrillation.

Insomnia Plus OSA Tied to Cerebrovascular Disease Risk

Comorbid insomnia and obstructive sleep apnea are linked to increased long-term risk for cardiovascular and cerebrovascular disease, a new study shows.

New US Anti-Fraud Measures: What Doctors Need to Know

The new CMS initiative dubbed CRUSH aims at cracking down on potentially fraudulent orders for molecular diagnostic tests and durable medical equipment.

Prompt Antithrombotics After GI Bleeds Benefits CVD Patients

Stopping antithrombotic therapy may be the most modifiable mechanism behind adverse cardiovascular outcomes after gastrointestinal bleeding.

Spain’s Cardiovascular Risk Standards Introduce Vascular Age

The Spanish Society of Arteriosclerosis releases updated 2026 standards that introduce the concept of vascular age to improve cardiovascular risk assessment.

Fermented Dairy and Metabolic Syndrome: Sex-Specific Link

Different types of dairy products show sex-specific associations with metabolic syndrome and its components, such as levels of lipid markers, a new Finnish study shows.

Todays Updates

Telemedicine Not Reaching Rural Psychiatric Patients

Telemedicine use is not associated with a substantial increase in mental health treatment among patients in rural, low-access, or distant communities, a new study shows.

Shorter but More Intense RT: A Better Option for HNSCC?

A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.

New Nanoparticles Can Destroy Undruggable Cancer Proteins

Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or immunotherapeutic payload to cancer cells.

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

A population-based cohort study finds that an increased use of adjuvant systemic therapy can improve survival in patients with metachronous and synchronous bilateral breast cancer.

Todays Updates

Telemedicine Not Reaching Rural Psychiatric Patients

Telemedicine use is not associated with a substantial increase in mental health treatment among patients in rural, low-access, or distant communities, a new study shows.

Shorter but More Intense RT: A Better Option for HNSCC?

A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.

New Nanoparticles Can Destroy Undruggable Cancer Proteins

Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or immunotherapeutic payload to cancer cells.

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

A population-based cohort study finds that an increased use of adjuvant systemic therapy can improve survival in patients with metachronous and synchronous bilateral breast cancer.

Latest News

An analysis of two large cohort studies finds that carriers of disease-causing variants within genes for three cardiomyopathies were at higher risk for atrial fibrillation.

Comorbid insomnia and obstructive sleep apnea are linked to increased long-term risk for cardiovascular and cerebrovascular disease, a new study shows.

The new CMS initiative dubbed CRUSH aims at cracking down on potentially fraudulent orders for molecular diagnostic tests and durable medical equipment.

Stopping antithrombotic therapy may be the most modifiable mechanism behind adverse cardiovascular outcomes after gastrointestinal bleeding.

The Spanish Society of Arteriosclerosis releases updated 2026 standards that introduce the concept of vascular age to improve cardiovascular risk assessment.

Different types of dairy products show sex-specific associations with metabolic syndrome and its components, such as levels of lipid markers, a new Finnish study shows.

News All Time

Primary Care for Kidney Failure Linked to Fewer ER Visits

Comprehensive care beyond dialysis is critical for patients with end-stage kidney disease.

Evidence Questions Routine Calcium Supplementation for Bones

Evidence from randomized trials suggests that calcium supplements may not significantly reduce fracture risk in well-nourished adults.

Immunofitness: Vaccination for Healthy Aging

A Spanish review suggests vaccines — influenza, RSV, COVID, pneumococcal, zoster, and others — may help preserve immune function in older adults and reduce hospitalizations.

Beyond GLP-1s: Which Weight-Loss Drugs Are on the Way?

Pharmaceutical company investments in novel obesity treatments are soaring in 2026.

Rising Childhood Obesity: Implications for Clinicians

In Brazil, an estimated 6.6 million children aged 5-9 years and 9.9 million adolescents aged 10-19 years are overweight or have obesity; clinicians should prioritize prevention and early intervention.

Sleep Apnea Measure May Predict Postop Complications, Death

In patients with obstructive sleep apnea undergoing major surgery, sleep apnea-specific hypoxic burden is associated with a risk for cardiovascular complications and deaths within 30 days.

Hypertrophic Cardiomyopathy: Do Family Members Face Risk?

Relatives with a pathogenic sarcomere gene variant have a lower risk for serious cardiac events than patients with hypertrophic cardiomyopathy but a higher risk than relatives without the variant.

PCPs Key to Cardiac Amyloidosis Detection in Obese Patients

The signs may be subtle, but clinicians have clues to look for.

Experts Warn Psychiatric Symptoms May Mask Hidden Disease

Takotsubo syndrome, frontotemporal dementia, gut-brain disorders, and tinnitus share psychiatric features that complicate their diagnosis and management.

Statins After 80? Lower Death Risk With Heart Benefit

In adults aged 80 years or older, the use of statins is linked to a lower risk for all-cause mortality and new coronary events.

Paclitaxel Devices Should Not Be Routine for Claudication

An MHRA advisory group says paclitaxel-coated balloons and stents should not be used routinely for intermittent claudication over mortality concerns.

AHA, ACC Issue Comprehensive Guidelines on Acute PE

The first multisociety guidelines on the diagnosis and management of acute pulmonary embolism feature a new classification system.

Therapy-Intense Training Linked to Improved Sleep Outcomes

Combining high-intensity circuit training with a sleep health program is tied to better sleep outcomes in sedentary women than either intervention alone, a new study shows.

Aspirin May Reduce Aortic Stenosis in People With High Lp(a)

New evidence shows regular aspirin use is associated with a lower incidence of aortic valve calcification and aortic stenosis, specifically in people with high lipoprotein(a).

The Many Cardiovascular Benefits of GLP-1 Drugs

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down to weight loss.

Recommended News For You

Through the activation of bitter taste receptors, lidocaine has the potential to kill some cancer cells.

Can Prior Authorization Be Better With Artificial Intelligence?

Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

Chronic pain and poor sleep are troublesome bed partners.

Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests

Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancer

Recommended Articles For You

An Overview Of Serum Osmolality: What Is It And How Can It Help You? 

Exploring Innovative Solutions for Infantile Hemangioma Treatment 

How EPCORITAMAB is Revolutionizing the Treatment of Cancer 

Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast cancer screening in women's 40s can save lives, study says

2.

Researchers publish action plan to address appendiceal cancer enigmas

3.

Novel probes to label macrophages associated with cancer progression using a selective dye

4.

Scholastic performance is a key concern for young cancer patients, study finds

5.

Updates from the 2022 WHO classification of kidney epithelial tumors

1.

Subchorionic Hematoma: Causes, Symptoms, and Treatment 

2.

Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support

3.

Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations

4.

The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies

5.

Transfusing the Future: Exploring the Possibilities of Blood Transfusions

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot